Donald Trump & Gilead Sciences

Donald Trump: His administration's funding cuts triggered the global decline, central to the event.

Gilead Sciences: Facing pressure to expand access to lenacapavir; its pricing and licensing decisions are under scrutiny.

Donald Trump: His administration dismantled USAID, triggering the aid cuts that prompted Byanyima's call for radical change.

Gilead Sciences: Developed lenacapavir, a highly effective HIV prevention injectable; faces potential revenue impact from generic production in South Africa.

Donald Trump: Donald Trump>>>'s administration has been criticized for cuts to foreign aid and withdrawal from the World Health Organization>>>, which experts say have weakened global health response capabilities, though he has expressed concern about the outbreak and pledged some funding.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.

Donald Trump: The Trump administration imposed a temporary ban on entry for non-US passport holders who visited Congo, Uganda, or South Sudan, and plans to send exposed Americans to a new facility in Kenya.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.

Donald Trump: The Trump administration's U.S. aid cuts forced the closure of many HIV care locations, making it difficult to reach vulnerable groups in South Africa.

Gilead Sciences: Gilead Sciences developed Lenacapavir and has committed to granting a voluntary manufacturing license to a South African company, which will allow for cheaper generic versions of the drug.

Donald Trump: Donald Trump>>>'s administration initiated the plan to send Ebola-exposed Americans to Kenya>>> and invoked public health laws to restrict entry from affected countries, reflecting his stance against allowing Ebola into the United States>>>.

Gilead Sciences: Gilead Sciences' antiviral remdesivir is mentioned as a potential treatment to be used at the quarantine facility, indicating its role in the medical response to Ebola.

Donald Trump: Donald Trump>>>'s administration's past decision to withdraw from the World Health Organization>>> and cut foreign aid was criticized for weakening surveillance systems.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Donald Trump: Trump criticized Fauci and his administration has questioned the pardon's validity. The event aligns with Trump's narrative against Fauci, potentially boosting his political support.

Gilead Sciences: Gilead is mentioned in relation to Remdesivir, but it is not directly involved in the event. Its role is peripheral.

Gilead Sciences: Gilead Sciences is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.